Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin¿s lymphoma patients at high risk of central nervous system disease in the rituximab era Sancho JM, Orfao A, Quijano S, García O, Panizo C, Pérez-Ceballos E, Deben G, Salar A, González-Barca E, Alonso N, García-Vela JA, Capote J, Peñalver FJ, Provencio M, Arias J, Plaza J, Caballero D, Morado M, Feliu E, Ribera JM. Spanish Group for the Study of CNS Disease in NHL. European Journal of Haematology 85:321-328. FI: 2.345 (Q3) Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping Costa ES, Pedreira CE, Barrena S, Lecrevisse Q, Flores J, Quijano S, Almeida J, del Carmen García-Macias M, Bottcher S, Van Dongen JJ, Orfao A. Leukemia 24:1927-1933. FI: 8.296 (Q1) Mobilization of plasma cells in healthy individuals treated with granulocyte colony-stimulating factor for haematopoietic stem cell collection Caraux A, Perez-Andres M, Larroque M, Requirand G, Lu ZY, Kanouni T, Rossi JF, Orfao A, Klein B. Immunology 132:266-272. FI: 3.276 (Q2) Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders Paiva B, Almeida J, Pérez-Andrés M, Mateo G, López A, Rasillo A, Vídriales MB, López-Berges MC, Miguel JF, Orfao A. Cytometry B 78B:239-252. FI: 1.727 (Q2) Gene expression profiles of human glioblastomas are associated with both tumour cytogenetics and histopathology Vital AL, Tabernero MD, Castrillo A, Rebelo O, Tao H, Gomes F, Nieto AB, Resende Oliveira C, Lopes MC, Orfao A. Oncology 12:991-1003. FI: 4.984 (Q1) Intratumoral cytogenetic heterogeneity of sporadic colorectal carcinomas suggests several pathways to liver metastasis Sayagues JM, Abad Mm, Barquero Melchor H, Gutierrez ML, Gonzalez-Gonzalez M, Jensen E, Bengoechea O, Fonseca E, Orfao A, Muñoz-Belvis L. Journal of Pathology 221:308-319. FI: 6.466 (Q1) Intratumoral patterns of clonal evolution in gliomas Vital Al, Tabernero MD, Crespo I, Rebelo O, Tao H, Gomes F, Lopes MC, Orfao A. Neurogenetics 11:227-239. FI: 3.486 (Q1) Mapping of genetic abnormalities of primary tumours from metastatic colorectal carcinomas by high-resolution SNP arrays Sayagues JM, Fontanillo C, Abad MM, Gonzalez-Gonzalez M, Sarasquete ME, Chillan MC, Garcia E, Bengoechea O, Fonseca E, Gonzalez-Diaz M, De Las Rivas J, Muñoz-Belvis L, Orfao A. PLOSone 5:e13752. FI: 4.351 (Q1) Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells Pérez-Persona E, Mateo G, García-Sanz R, Mateos MV, de Las Heras N, de Coca AG, Hernández JM, Galende J, Martín-Nuñez G, Bárez A, Alonso JM, Martín A, López-Berges C, Orfao A, San Miguel JF, Vidriales MB. British Journal of Haematology 148:110-114. FI: 4.597 (Q1) CD117 expression is gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features Schmidt-Hieber M, Pérez-Andrés M, Paiva B, Flores-Montero J, Perez JJ, Gutierrez NC, Vidriales MB, Matarraz S, San Miguel JF, Orfao A. Haematologica 96:328-332. FI: 6.416 (Q1)
|
